Notably, in both leukemia and breast cancer model systems, the downregulation of this key players in the NF-κB signaling was also associated with an increased cytoplasmic localization of the transcription factor where it is generally inactivated by IKBA. Here, NFKB1 is linked to breast carcinoma.